Innovative Biotechnology

Our portfolio companies aim to develop interventions that can significantly improve quality of life today by targeting the features of aging.


Aeonian Pharmaceuticals a San Francisco Bay Area-based R&D-stage biopharmaceutical company developing novel and highly selective therapeutics modulating the mTORC1 pathway.

Cleara Biotech is a preclinical R&D company engaged in the creation of therapeutics targeting cellular senescence by designing novel compounds that selectively eliminate senescent cells.

Samsara Therapeutics is a drug discovery and development platform focused on identification, chemical optimization, and in vivo validation of new compounds that extend healthy lifespan.